Jushi Holdings (JUSHF) Total Non-Current Liabilities (2020 - 2026)

Jushi Holdings (JUSHF) reported Total Non-Current Liabilities of $494.8 million for Q1 2026, up 12.74% year-over-year from $438.9 million in Q1 2025, and up 4.95% quarter-over-quarter from $471.5 million in Q4 2025.

Jushi Holdings (JUSHF) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

Jushi Holdings (JUSHF) has 7 years of Total Non-Current Liabilities data on file, last reported at $494.8 million in Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $494.8 million, up 12.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $494.8 million (up 12.74% YoY), and the FY2025 annual result was $471.5 million, up 11.82% from the prior year.
  • Total Non-Current Liabilities advanced to $494.8 million in Q1 2026 per JUSHF's latest filing, from $471.5 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $494.8 million in Q1 2026 and troughed at $259.3 million in Q3 2022.
  • A 5-year average of $382.6 million and a median of $375.8 million in 2022 frame the typical range for Total Non-Current Liabilities.
  • On a YoY basis, Total Non-Current Liabilities climbed as much as 40.61% in 2023 and fell as far as 17.9% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $375.8 million in 2022, then fell by 17.9% to $308.6 million in 2023, then soared by 36.66% to $421.7 million in 2024, then grew by 11.82% to $471.5 million in 2025, then rose by 4.95% to $494.8 million in 2026.
  • Business Quant data shows JUSHF's Total Non-Current Liabilities at $494.8 million in Q1 2026, $471.5 million in Q4 2025, and $424.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 18.28 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 2.44 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 1.81 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.13 Bn
10 Jushi Holdings - - 29.88 Mn 494.85 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 494.85 Mn
Dec 31, 2025 471.50 Mn
Sep 30, 2025 423.98 Mn
Jun 30, 2025 447.08 Mn
Mar 31, 2025 438.92 Mn
Dec 31, 2024 421.66 Mn
Sep 30, 2024 411.23 Mn
Jun 30, 2024 405.29 Mn
Mar 31, 2024 317.14 Mn
Dec 31, 2023 308.55 Mn
Sep 30, 2023 364.58 Mn
Jun 30, 2023 346.39 Mn
Mar 31, 2023 368.98 Mn
Dec 31, 2022 375.82 Mn
Sep 30, 2022 259.28 Mn
Jun 30, 2022 330.09 Mn
Mar 31, 2022 318.06 Mn
Dec 31, 2021 387.14 Mn
Dec 31, 2020 -207.78 Mn